Heart failure survival among older adults in the United States: A poor prognosis for an emerging epidemic in the Medicare population

Archives of Internal Medicine

Volumn 159, Issue 5, 1999, Pages 505-510

  Croft, Janet B ^a   Giles, Wayne H ^a   Pollard, Robert A ^a   Keenan, Nora L ^a   Casper, Michele L ^a   Anda, Robert F ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL; UNITED STATES;

EID: 0033535360     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.5.505     Document Type: Article

References (46)

1. Lenfant C. Fixing the failing heart. Circulation. 1997;95:771-772.
2. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45:968-974.
3. Centers for Disease Control and Prevention. Mortality from congestive heart failure -United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1994;43:77-81.
4. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986: evidence for increasing population prevalence. Arch Intern Med. 1990;150:769-773.
5. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J. 1993; 126:1042-1047.
6. Croft JB, Giles WH, Pollard RA, Casper ML, Anda RF, Livengood JR. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc. 1997;45: 270-275.
7. Centers for Disease Control and Prevention. Trends in ischemic heart disease mortality - United States, 1980-1988. MMWR Morb Mortal Wkly Rep. 1992;41: 548-549, 555-556.
8. Centers tor Disease Control and Prevention. Cerebrovascular disease mortality and Medicare hospitalization - United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1992;41:477-480.
9. Yusuf S, Thom T, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension. 1989;13(suppl 5):174-179.
10. Armstrong PW, Moe GW. Medical advances in the treatment of congestive heart failure. Circulation. 1994;88:2941-2952.
11. Konstam MA, Dracup K, Baker DW, et al. Heart Failure: Evaluation and Care of Patients With Left Ventricular Systolic Dysfunction. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services; June 1994. Clinical Practice Guideline No. 11. AHCPR publication No. 94-0612.
12. Baker DW, Konstam MA, Bottorff M, Pitt B. Management of heart failure, I: pharmacologic treatment. JAMA. 1994;272:1361-1366.
13. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA. 1994;271:1276-1280.
14. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA Task Force report: guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol. 1995;26:1376-1398.
15. Croft JB, Giles WH, Roegner RH, Anda RF, Casper ML, Livengood JR. Pharmacologic management of heart failure among older adults by office-based physicians in the United States. J Fam Pract. 1997;44:382-390.
16. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997; 157:2460-2464.
17. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(suppl A):6A-13A.
18. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301-306.
19. Alexander M, Grumbach K, Selby J, Brown AF, Washington E. Hospitalization for congestive heart failure: explaining racial differences. JAMA. 1995;274:1037-1042.
20. Kahn KL, Pearson ML, Harrison ER, et al. Health care for black and poor hospitalized Medicare patients. JAMA 1994;271:1169-1174.
21. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol. 1993;22(suppl A):14A-19A.
22. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
23. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute Inc; 1995.
24. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation. 1987;75(5, pt 2):IV11-IV19.
25. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
26. Rouleau J, Shenasa M, de Champlain J, Nadeau R. Predictors of survival and sudden death in patients with stable severe congestive heart failure due to ischemic and nonischemic causes: a prospective long-term study of 200 patients. Can J Cardiol. 1990;6:453-460.
27. Taffet GE, Teasdale TA, Bleyer AJ, Kutka NJ, Luchi RJ. Survival of elderly men with congestive heart failure. Age Aging. 1992;21:49-55.
28. Wolinsky FD, Smith DM, Stump TE, Overhage JM, Lubitz RM. The sequelae of hospitalization for congestive heart failure among older adults. J Am Geriatr Soc. 1997;45:558-563.
29. May DS, Casper ML, Croft JB, Giles WH. Trends in survival after stroke among Medicare beneficiaries. Stroke. 1994;25:1617-1622.
30. Franks AL, May DS, Wenger NK, Blount SB, Eaker ED. Racial differences in the use of invasive coronary procedures after acute myocardial infarction in Medicare beneficiaries. Ethn Dis. 1993;3:213-220.
31. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993;270:1832-1836.
32. Peterson ED, Jollis JG, Bebchuk JD, et al. Changes in mortality after myocardial revascularization in the elderly: the national Medicare experience. Ann Intern Med. 1994;121:919-927.
33. Jencks SF, Williams DK, Kay TL. Assessing hospital-associated deaths from discharge data: the role of length of stay and comorbidities. JAMA 1988;260:2240-2246.
34. Iezzoni LI, Foley SM, Daley J, et al. Comorbidities, complications, and coding bias: does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA. 1992;267:2197-2203.
35. Pashos CL, Normand SLT, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol. 1994;23:1023-1030.
36. ManolioTA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
37. Glynn RJ, Brock DB, Harris T, et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med. 1995;155:1855-1860.
38. Psaty BM, Koepsell TD, Yanez DN, et al. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992: an effect of the major clinical trials on clinical practice? JAMA. 1995;273:1436-1438.
39. Hsia DC, Krushat WM, Fagan AB, et al. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med. 1988;318: 352-355.
40. Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health. 1992;82:243-248.
41. Record high life expectancy. Stat Bull Metrop Insur Co.. 1993;74:28-35.
42. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325:293-302.
43. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
44. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med. 1997;157:1103-1108.
45. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD). South Med J. 1995;88:514-523.
46. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997;133:703-712.